This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Anatomic Pathology Market

Market Insights on Anatomic Pathology covering sales outlook, demand forecast & up-to-date key trends

Anatomic Pathology Market by Product & Service, Application, End User & Region - Forecast 2022 - 2030

Anatomic Pathology Market Outlook (2022-2030)

[290 Pages Report] The global anatomic pathology market size reached a valuation of US$ 32.5 Mn in 2022 and is likely to grow at a robust CAGR of 8.2% between 2022 and 2030, surpassing US$ 61.1 Mn by the end of 2030. Growth in the global anatomic pathology market is driven by rising application of anatomic pathology in disease diagnosis and drug discovery and development.

Anatomic Pathology Market Size (2022)

US$ 32.5 Mn

Anatomic Pathology Market Revenue Forecast (2030)

US$ 61.1 Mn

Anatomic Pathology Market Growth Rate (2022-2030)

8.2% CAGR

North America Market Share

37.1%

Anatomic pathology is a medical specialty that focuses on identifying diseases on the basis of microscopic, macroscopic, immunologic, biochemical, and molecular examinations of organs and tissues. Its (anatomical pathology) main role is to identify abnormalities that can help to diagnose disease and manage treatment.

The adoption of anatomic pathology has shown promising results in identifying and managing various types of tumors or cancers, kidney and liver diseases, autoimmune disorders etc. As a result, it is often being used in end use verticals such as hospitals, research laboratories, and diagnostic laboratories.

Rising prevalence of numerous diseases coupled with growing need for early detection of chronic diseases and rapidly expanding healthcare industry is providing a strong thrust to the growth of anatomic pathology market and the trend is likely to continue during the forecast period.

Consequently, increasing usage of biomarkers, advances in histology, and rapid expansion of cellular pathology market will positively impact the anatomic pathology market projections in future. Over the years, biomarkers have become quite popular as they allow pathologists to determine disease causation at the molecular level, which aids clinical decision-making and improves patient outcomes.

Currently, anatomic pathology accounts for 0.2% share of the global pathology market and this number is expected to increase substantially on account of rising applications of anatomic pathology in numerous applications.

Regionally, North America will continue to dominate the global anatomic pathology market, accounting for around 37.1% share through 2030. Growth in the North American anatomic pathology market is driven by strong presence of major market players, favorable government policies connected to pathological training programs, availability of advanced technologies, favorable reimbursement scenarios for anatomic pathology diagnostic tests, and rising healthcare expenditures

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

8.21%

H1, 2022 Projected

8.20%

H1, 2022 Outlook

7.80%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 40 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 41 ↓

The comparative analysis and market growth rate of global anatomic pathology market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 40 BPS, and, a negative BPS growth is expected in H1-2022 over H1- 2021 duration with 41 Basis Point Share (BPS).

The key developments in the market include the design of Biophotonics in pathology to describe various types of imaging methods available. This factor has enforced the factor of pathology and radiology to converge towards a more holistic approach to diagnostic imaging, thus playing as a major driving factor for growth of the market.

The market observes a decline in the BPS values owed to the decreased flexibility in work force staffing, when compared with general service providers such as laboratories, high operational costs and overheads with each unit of subspecialty operating, and a greater need for trained staff, among others.

Several new approaches, such as cryoelectron tomography, holographic tissue dynamics spectroscopy, cellular magnetic resonance imaging, exotic material lensing, and photoacoustic tomography are further set to propel the market growth over the coming years.

Anatomic Pathology Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2030)

The global demand for anatomic pathology products and services is projected to grow at a healthy CAGR of 8.2% during the forecast period between 2022 and 2030, totaling over US$ 61.1 Bn by 2030. Factors such as rising prevalence of cancer and other target diseases, growing demand for personalized medicine, escalating need for early diagnosis of chronic diseases, surge in R&D activities, and introduction of favorable reimbursement policies are driving the anatomic pathology industry growth.

Anatomic pathology has become one of the most commonly used techniques for the detection and management of diseases like cancer. It allows pathologists to determine the cause and effect of particular diseases by analyzing tissues and organs during biopsies and other medical procedures.

Rapid surge in cancer cases across the globe is providing a major impetus to the growth of anatomic pathology market and the trend is likely to continue during the forecast period. According to the American Cancer Society, it is estimated that the global cancer burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. This will create immense demands for advanced diagnostic technologies and treatment approaches, thereby expanding the anatomic pathology market size.

Furthermore, advancements in anatomic pathology instruments will significantly aid in improving the anatomic pathology market share during the forecast period. Leading anatomic pathology manufacturers are continuously focusing on introducing advanced digital products such as specimen tracking systems (STS), to empower anatomical pathologists to accurately diagnose diseases and make confident treatment decisions.

Additionally, growing awareness, increasing healthcare expenditure, escalating cancer research, and rise in the use of biomarkers during illness diagnosis will boost the anatomic pathology market growth during the forthcoming years.

Based on the aforementioned factors, FMI’s latest report on anatomic pathology market forecast the global anatomic pathology market to expand at 1.88X by 2030.

Anatomic Pathology Market Download Report Brochure

Which Factors are Challenging the Growth of Anatomic Pathology Market?

Despite its optimistic stance, the global anatomic pathology market is facing various obstacles that are challenging its growth to some extent. Some of these obstacles include the availability of refurbished anatomic pathology equipment, frequent product recalls, and adoption of alternative diagnostic techniques.

Today, various refurbished anatomic pathology devices such as tissue processors, microtomes, and staining systems are available from LabX (US), Rankin Biomedical Corporation (US), Swerdlick Medical Systems (US), and AL-TAR (US). Availability of these refreshed anatomic pathology products is expected to negatively impact the revenue of companies selling branded anatomic pathology devices.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Analysis

How is the Growth Projection for the U.S. Anatomic Pathology Market?

“Rising Investments in Research and Development Creating Space for Anatomic Pathology Market Growth in the U.S.”

As per FMI, the U.S. is expected to account for a significant share of the global anatomic pathology market through 2030, owing to the rising prevalence of cancer, high research and development funding, availability of favorable reimbursement policies, increasing adoption of pathology imaging systems, surge in anatomic pathology labs, flourishing human anatomical models market, and strong presence of leading anatomic pathology m market players.

Over the years, the U.S. has become a global leader in medical research. The country annually spends billions of dollars on research and development to advance personalized medicine and reduce the burden of chronic diseases. For instance, the National Institutes of Health (NIH) alone spends about US$ 41.7 billion annually in medical research for the American people.

Similarly, rise in the number of new anatomic pathology product launches and approvals will improve the anatomic pathology market share of the U.S. during the forecast period.

How Will Growth Unfold in the Germany Anatomic Pathology Market?

“Availability of Advanced Pathology Devices and Increasing Number of Anatomic Pathology Service Providers Spurring Growth in the Germany Anatomic Pathology Market”

With rising prevalence of chronic diseases and availability of advanced pathology devices, the anatomic pathology market in Germany is expected to grow at a strong CAGR during the forecast period between 2022 and 2030.

As the burden of cancer and other chronic diseases across Germany continue to rise, medical institutes and government organizations are putting various efforts to tackle the situation. They are increasingly investing in advanced diagnostic technologies to improve the diagnostic screening and reduce healthcare burden. This is creating a conducive environment for the anatomic pathology industry growth in the country.

The Europe anatomic pathology market, spearheaded by Germany and the U.K. is expected to account for 25.7% of the global market share.

Category-wise Analysis

Based on Product and Service, Which Segment Accounts for the Largest Share of Anatomic Pathology market?

“Demand for Anatomic Pathology Services to Remain High Throughout the Forecast Period”

As per FMI, the anatomic pathology services segment is likely to account for the largest share of the global anatomic pathology market during the forecast period, owing to the rapid surge in cancer cases, availability of favorable reimbursement for diagnostic tests, and increase in the number of anatomic pathology service providers worldwide.

Which is the Most Lucrative Application of Anatomic Pathology?

“Disease Diagnosis Segment to Contribute Most to the Global Anatomic Pathology Market”

Based on application, the global anatomic pathology market is segmented into disease diagnosis, drug discovery and development and others. Among these, disease diagnosis segment accounted for the largest share in 2021, and is likely to grow at a relatively higher CAGR during the assessment period, as per the latest anatomic pathology market trends. This can be attributed to rising incidence of cancer and other chronic diseases, growing need for early diagnosis of these diseases to initiate proper treatment, and various initiatives launched by government to facilitate diagnostic screening of chronic disease.

Similarly, expansion of cancer tissue diagnostics market and advancements in tissue diagnostics will support the growth of this segment during the forthcoming years.

Which End User Segment Dominates the Global Anatomic Pathology Market?

“Demand for Anatomic Pathology Products and Services to Remain High in Hospitals”

Based on end user, anatomic pathology market has been segmented into hospitals, research laboratories, diagnostic laboratories, and others. As per FMI, hospital segment held the largest share of anatomic pathology market in 2021 and the trend is likely to continue during the forecast period, owing to the rising number of patient visits to hospitals, growing awareness among people regarding the importance of early diseases diagnosis, and rapid increase in the number of hospitals worldwide.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Who are Some of the Leading Players in Anatomic Pathology Market?

Some of the leading anatomic pathology providers include Laboratory Corporation of America Holdings, F.Hoffmann-La Roche AG, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Cardinal Health, Inc., BioGenex, NeoGenomics, Bio SB, and Agilent Technologies.

Players like Roche have become global leaders in solutions for anatomical pathology labs to diagnose cancers. They are continuously investing in research and development to advance in personalized healthcare and integrate digital tools in anatomic pathology. For instance,

  • In 2021, Roche launched two new automated digital pathology algorithms called uPath HER2 image analysis and uPath HER2 Dual ISH image analysis, to support pathologists in making fast and accurate patient diagnoses in breast cancer.
  • In 2022, Roche collaborated with Bristol Myers Squibb to advance personalized healthcare through digital pathology solutions.

Similarly, various leading players are adopting strategies like new product launches, acquisitions, mergers, partnerships, and collaborations to gain a competitive edge in the global anatomic pathology market. For instance,

  • In 2021, Inform diagnostics, a leading U.S. anatomic pathology provider, collaborated with Paige, a global leader in AI-based cancer diagnostics software for digital pathology, to integrate digital solutions with anatomic pathology diagnostics.
  • In June 2022, EmeritusDX acquired Freedom Pathology Partners to further expand its national presence in providing anatomic pathology, molecular testing, and fluorescence in situ hybridization.

Anatomic Pathology Industry Report Scope

Future Market Insights latest report provides a detailed anatomic pathology market forecast for a period of 8 years (2022-2030). It examines how advancement in anatomic pathology is revolutionizing the disease diagnosis and drug discovery services markets

The report is intended to enlighten customers with significant details about market shaping factors including drivers, restraints, emerging opportunities and latest anatomic pathology market trends.

While developed nations like the United States, Germany, and the United Kingdom remain at the top of the ladder, factors pushing anatomic pathology industry growth across emerging economies such as India and China have been thoroughly discussed.

FMI also illustrates how rise in chronic diseases and increasing investments in R&D will expand the global anatomic pathology market size during the forthcoming years. Besides this, it offers insights into leading anatomic pathology manufacturers and their growth strategies.

The Anatomic Pathology Market Analysis Includes:

  • An 8-year realistic sales forecast of anatomic pathology across several end use verticals
  • Insights into futuristic anatomic pathology market projections
  • Market dynamics including drivers, restraints, and emerging opportunities
  • Details about key players operating in anatomic pathology market and their respective growth strategies to penetrate attractive markets
  • Information about lucrative regional pockets and leading anatomic pathology market segments
  • Recent advances in anatomic pathology market
  • The winning imperatives in anatomic pathology market
  • Opportunity assessment
  • Pricing analysis

Scope of Report

Attribute

Details

Forecast Period

2022-2030

Historic Data Available for

2015-2021

Market Analysis

USD Million for Value

Report Coverage

Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives

Key Segments Covered

  • Product & Service
  • Application
  • End User
  • Region

Key regions covered

North America

  • US
  • Canada
  • Rest of North America

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Western Europe

  • Germany
  • U.K.
  • France
  • Rest of Western Europe

Eastern Europe

  • Russia
  • Spain
  • Rest of Eastern Europe

South Asia Pacific

  • China
  • India
  • Japan
  • Malaysia
  • Thailand
  • Indonesia
  • South Korea
  • Rest of South Asia & Pacific

Middle East & Africa GCC Countries

  • Turkey
  • Israel
  • Rest of MEA

Rest of the World

  • Oceania
  • Africa
  • South America

End User

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Key companies profiled

Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., F.Hoffmann-La Roche AG, Cardinal Health, Inc.,BioGenex, NeoGenomics, Bio SB, Agilent Technologies

Customization & pricing

Available upon request

Key Segments of Anatomic Pathology Industry Survey

Anatomic Pathology Market by Product & Service:

  • Anatomic Pathology Instruments
  • Anatomic Pathology Consumables
  • Anatomic Pathology Services

Anatomic Pathology Market by Application:

  • Disease Diagnosis
  • Drug Discovery and Development
  • Others

Anatomic Pathology Market by End User:

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Anatomic Pathology Market by Region:

  • North America Anatomic Pathology Market
  • Latin America Anatomic Pathology Market
  • Europe Anatomic Pathology Market
  • East Asia Anatomic Pathology Market
  • South Asia & Pacific Anatomic Pathology Market
  • Middle East & Africa (MEA) Anatomic Pathology Market

Frequently Asked Questions

As per FMI, the global anatomic pathology market was valued at US$ 32.5 Mn in 2022.

The global anatomic pathology market is expected to grow at 8.2% CAGR during the forecast period between 2022 to 2030.

The anatomic pathology market is projected to reach US$ 61.1 Mn by 2030.

Laboratory Corporation of America Holdings, Sakura Finetek USA, Inc., BioGenex, Quest Diagnostics Incorporated, F.Hoffmann-La Roche AG, Cardinal Health, Inc., NeoGenomics, and Bio SB are some of the leading players operating in anatomic pathology market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

    3.3. Innovations & New Launches

4. Market Context

    4.1. Product USPs/ Features

    4.2. Disease Epidemiology

    4.3. Product USPs/ Features

    4.4. Strategic Promotional Strategies

    4.5. Regulatory Scenario

    4.6. Product Adoption in Primary diagnosis

    4.7. Regulatory Scenario

5. COVID19 Crisis Analysis

    5.1. Current COVID19 Statistics and Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 financial analysis

    5.4. COVID19 and Impact Analysis

        5.4.1. Revenue By Product

        5.4.2. Revenue By Area of Application

        5.4.3. Revenue By Country

    5.5. 2022 Market Scenario

    5.6. Quarter by Quarter Forecast

    5.7. Projected recovery Quarter

    5.8. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Global GDP Growth Outlook

        6.1.2. Global Healthcare Outlook

    6.2. Forecast Factors - Relevance & Impact

        6.2.1. Research and Developmental Activities

        6.2.2. Technological Advancement

        6.2.3. Adoption of Anatomic Pathology

        6.2.4. Reimbursement in Anatomic Pathology

        6.2.5. Advances in Preventative Diagnosis

        6.2.6. Focus of Manufacturer to Launch Innovative Products

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunities

7. Global Anatomic Pathology Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Product & Services Type

    7.2. Pricing Break-up*

        7.2.1. Provider Level Pricing

        7.2.2. Service Level Pricing

    7.3. Global Average Pricing Analysis Benchmark*

8. Global Anatomic Pathology Market Value (US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030

    8.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Opportunity Analysis, 2022-2030

9. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, By Product & Services Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Product & Services Type, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product & Services Type, 2022-2030

        9.3.1. Instruments

            9.3.1.1. Microtomes & Cryostat

            9.3.1.2. Tissue processors

            9.3.1.3. Automatic Stainers

            9.3.1.4. Other products

        9.3.2. Consumables

            9.3.2.1. Reagents & Antibodies

            9.3.2.2. Probes & Kits

            9.3.2.3. Others

        9.3.3. Services

            9.3.3.1. Histopathology

            9.3.3.2. Cytopathology

    9.4. Market Attractiveness Analysis By Product & Services Type

10. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, By Area of Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Area of Application, 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Area of Application, 2022-2030

        10.3.1. Disease Diagnosis

        10.3.2. Drug Discovery and Development

        10.3.3. Others

    10.4. Market Attractiveness Analysis By Area of Application

11. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2030

        11.3.1. Hospitals

        11.3.2. Research Laboratories

        11.3.3. Diagnostic Laboratories

        11.3.4. Others

    11.4. Market Attractiveness Analysis By End User

12. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, by Region

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2030

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa

    12.4. Market Attractiveness Analysis By Region

13. North America Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Product & Services Type

        13.3.3. By Area of Application

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        14.3.1. By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Product & Services Type

        14.3.3. By Area of Application

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Europe Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Product & Services Type

        15.3.3. By Area of Application

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. South Asia Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Product & Services Type

        16.3.3. By Area of Application

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. East Asia Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Product & Services Type

        17.3.3. By Area of Application

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Oceania Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021

    18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product & Services Type

        18.3.3. By Area of Application

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021

    19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Turkey

            19.3.1.3. South Africa

            19.3.1.4. Rest of Middle East and Africa

        19.3.2. By Product & Services Type

        19.3.3. By Area of Application

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Key and Emerging Countries Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. Anatomic Pathology Market Analysis

        20.2.1. By Product & Services Type

        20.2.2. By Area of Application

        20.2.3. By End User

    20.3. Canada Anatomic Pathology Market Analysis

        20.3.1. By Product & Services Type

        20.3.2. By Area of Application

        20.3.3. By End User

    20.4. Mexico Anatomic Pathology Market Analysis

        20.4.1. By Product & Services Type

        20.4.2. By Area of Application

        20.4.3. By End User

    20.5. Brazil Anatomic Pathology Market Analysis

        20.5.1. By Product & Services Type

        20.5.2. By Area of Application

        20.5.3. By End User

    20.6. U.K. Anatomic Pathology Market Analysis

        20.6.1. By Product & Services Type

        20.6.2. By Area of Application

        20.6.3. By End User

    20.7. Germany Anatomic Pathology Market Analysis

        20.7.1. By Product & Services Type

        20.7.2. By Area of Application

        20.7.3. By End User

    20.8. France Anatomic Pathology Market Analysis

        20.8.1. By Product & Services Type

        20.8.2. By Area of Application

        20.8.3. By End User

    20.9. Italy Anatomic Pathology Market Analysis

        20.9.1. By Product & Services Type

        20.9.2. By Area of Application

        20.9.3. By End User

    20.10. Spain Anatomic Pathology Market Analysis

        20.10.1. By Product & Services Type

        20.10.2. By Area of Application

        20.10.3. By End User

    20.11. BENELUX Anatomic Pathology Market Analysis

        20.11.1. By Product & Services Type

        20.11.2. By Area of Application

        20.11.3. By End User

    20.12. Russia Anatomic Pathology Market Analysis

        20.12.1. By Product & Services Type

        20.12.2. By Area of Application

        20.12.3. By End User

    20.13. China Anatomic Pathology Market Analysis

        20.13.1. By Product & Services Type

        20.13.2. By Area of Application

        20.13.3. By End User

    20.14. Japan Anatomic Pathology Market Analysis

        20.14.1. By Product & Services Type

        20.14.2. By Area of Application

        20.14.3. By End User

    20.15. South Korea Anatomic Pathology Market Analysis

        20.15.1. By Product & Services Type

        20.15.2. By Area of Application

        20.15.3. By End User

    20.16. India Anatomic Pathology Market Analysis

        20.16.1. By Product & Services Type

        20.16.2. By Area of Application

        20.16.3. By End User

    20.17. ASEAN Anatomic Pathology Market Analysis

        20.17.1. By Product & Services Type

        20.17.2. By Area of Application

        20.17.3. By End User

    20.18. Australia Anatomic Pathology Market Analysis

        20.18.1. By Product & Services Type

        20.18.2. By Area of Application

        20.18.3. By End User

    20.19. New Zealand Anatomic Pathology Market Analysis

        20.19.1. By Product & Services Type

        20.19.2. By Area of Application

        20.19.3. By End User

    20.20. GCC Countries Anatomic Pathology Market Analysis

        20.20.1. By Product & Services Type

        20.20.2. By Area of Application

        20.20.3. By End User

    20.21. Turkey Anatomic Pathology Market Analysis

        20.21.1. By Product & Services Type

        20.21.2. By Area of Application

        20.21.3. By End User

    20.22. South Africa Anatomic Pathology Market Analysis

        20.22.1. By Product & Services Type

        20.22.2. By Area of Application

        20.22.3. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players

    21.3. Market Presence of Parallel Industries

    21.4. Market Presence Analysis

        21.4.1. Regional Footprint by Players

        21.4.2. Product Foot print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive (Tentative List*)

        22.3.1. F. Hoffmann-La Roche AG

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

                22.3.1.5.1. Marketing Strategy

                22.3.1.5.2. Product Strategy

                22.3.1.5.3. Channel Strategy

        22.3.2. Danaher Corporation

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

                22.3.2.5.1. Marketing Strategy

                22.3.2.5.2. Product Strategy

                22.3.2.5.3. Channel Strategy

        22.3.3. Hologic, Inc

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

                22.3.3.5.1. Marketing Strategy

                22.3.3.5.2. Product Strategy

                22.3.3.5.3. Channel Strategy

        22.3.4. Thermo Fisher Scientific, InC

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

                22.3.4.5.1. Marketing Strategy

                22.3.4.5.2. Product Strategy

                22.3.4.5.3. Channel Strategy

        22.3.5. Agilent Technologies

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

                22.3.5.5.1. Marketing Strategy

                22.3.5.5.2. Product Strategy

                22.3.5.5.3. Channel Strategy

        22.3.6. Becton, Dickinson and Company

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

                22.3.6.5.1. Marketing Strategy

                22.3.6.5.2. Product Strategy

                22.3.6.5.3. Channel Strategy

        22.3.7. PHP Holdings Corporation

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

                22.3.7.5.1. Marketing Strategy

                22.3.7.5.2. Product Strategy

                22.3.7.5.3. Channel Strategy

        22.3.8. Sakura Finetek USA Inc

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

                22.3.8.5.1. Marketing Strategy

                22.3.8.5.2. Product Strategy

                22.3.8.5.3. Channel Strategy

        22.3.9. Merck KGaA

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.9.4. Sales Footprint

            22.3.9.5. Strategy Overview

                22.3.9.5.1. Marketing Strategy

                22.3.9.5.2. Product Strategy

                22.3.9.5.3. Channel Strategy

        22.3.10. Bio SB

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.10.4. Sales Footprint

            22.3.10.5. Strategy Overview

                22.3.10.5.1. Marketing Strategy

                22.3.10.5.2. Product Strategy

                22.3.10.5.3. Channel Strategy

        22.3.11. Diapath S.p.A.

            22.3.11.1. Overview

            22.3.11.2. Product Portfolio

            22.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.11.4. Sales Footprint

            22.3.11.5. Strategy Overview

                22.3.11.5.1. Marketing Strategy

                22.3.11.5.2. Product Strategy

                22.3.11.5.3. Channel Strategy

        22.3.12. BioGenex Laboratories

            22.3.12.1. Overview

            22.3.12.2. Product Portfolio

            22.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.12.4. Sales Footprint

            22.3.12.5. Strategy Overview

                22.3.12.5.1. Marketing Strategy

                22.3.12.5.2. Product Strategy

                22.3.12.5.3. Channel Strategy

        22.3.13. Cardinal Health, Inc

            22.3.13.1. Overview

            22.3.13.2. Product Portfolio

            22.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.13.4. Sales Footprint

            22.3.13.5. Strategy Overview

                22.3.13.5.1. Marketing Strategy

                22.3.13.5.2. Product Strategy

                22.3.13.5.3. Channel Strategy

        22.3.14. Quest Diagnostics Incorporated

            22.3.14.1. Overview

            22.3.14.2. Product Portfolio

            22.3.14.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.14.4. Sales Footprint

            22.3.14.5. Strategy Overview

                22.3.14.5.1. Marketing Strategy

                22.3.14.5.2. Product Strategy

                22.3.14.5.3. Channel Strategy

        22.3.15. Laboratory Corporation of America Holdings

            22.3.15.1. Overview

            22.3.15.2. Product Portfolio

            22.3.15.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.15.4. Sales Footprint

            22.3.15.5. Strategy Overview

                22.3.15.5.1. Marketing Strategy

                22.3.15.5.2. Product Strategy

                22.3.15.5.3. Channel Strategy

        22.3.16. NeoGenomics Laboratories Inc

            22.3.16.1. Overview

            22.3.16.2. Product Portfolio

            22.3.16.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.16.4. Sales Footprint

            22.3.16.5. Strategy Overview

                22.3.16.5.1. Marketing Strategy

                22.3.16.5.2. Product Strategy

                22.3.16.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 02: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 03: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 04: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 05: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Region

Table 06: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 07: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 08: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 09: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 10: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 11: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 12: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 13: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 14: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 15: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 16: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 17: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 18: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 19: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 20: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 21: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 22: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Typeh Table 23: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 24: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 25: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 26: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 27: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 28: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 29: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 30: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 31: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 32: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 33: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 34: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 35: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 36: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 37: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 38: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 39: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 40: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 41: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 42: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 43: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 44: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 45: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 46: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 47: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 48: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 49: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 50: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 51: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 52: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Table 01: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 02: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 03: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 04: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 05: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Region

Table 06: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 07: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 08: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 09: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 10: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 11: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 12: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 13: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 14: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 15: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 16: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 17: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 18: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 19: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 20: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 21: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 22: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Typeh Table 23: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 24: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 25: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 26: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 27: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 28: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 29: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 30: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 31: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 32: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 33: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 34: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 35: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 36: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country

Table 37: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 38: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 39: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 40: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 41: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 42: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 43: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 44: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 45: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 46: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 47: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 48: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Table 49: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 50: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type

Table 51: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application

Table 52: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Cellular Pathology Market

Published : June 2018

Healthcare

Quantitative Pathology Imaging Market

Published : September 2017

Healthcare

Pathology Devices Market

Published : January 2016

Healthcare

Digital Pathology Market

Published : August 2021

Google translate

Anatomic Pathology Market